Evidence map›Paper›PMID 40928984›Full record

ArticleBiopreservation and biobanking2026

The Development of the Biobank Collections Valuator as an Automated Tool to Determine the Noneconomic Value of Sample Collections.

Joseph A Kessler, Tali M Johnson, Marianne K Henderson

Abstract read
In one paragraph

Article in Biopreservation and biobanking, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph A KesslerIndependent Consultant, New Richmond, Ohio, USA.ORCID 0009-0009-5193-2004
Tali M JohnsonNational Cancer Institute, NIH, Bethesda, Maryland, USA.
Marianne K HendersonNational Cancer Institute, NIH, Bethesda, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biobankers rely on their experience, supplemented with a variety of tools, to help establish and sustain their operations. These tools support operations, cost determination, quality management, and governance. Costing tools have often been used to determine the economic value of a single specimen or an entire collection, with the purpose of allowing researchers to recover costs when providing access to those resources. Until recently, biobank managers have focused on deriving sample value based solely on cost-model analyses. We propose an alternative way to value collections using a web-based, automated tool for biobankers to determine the noneconomic value of biospecimen collections. The tool supports fit-for-purpose determinations for collections using common attributes and defined criteria to facilitate broader sample utility, sharing, and overall sustainability in operations.

Indexed as

Biological Specimen BanksSpecimen HandlingHumansbiobank collectionsbiobank operationsbusiness planningnoneconomic collection value determination

Identifiers

PMID40928984
PMCPMC13123744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.